Attention A T users. To access the menus on this page please perform the following steps.
1. Please switch auto forms mode to off.
2. Hit enter to expand a main menu option (Health, Benefits, etc).
3. To enter and activate the submenu links, hit the down arrow.
You will now be able to tab or arrow up or down through the submenu options to access/activate the submenu links.
Locator
Contact
Search
Search
VA »
Health Care »
Pharmacy Benefits Management Services
»
Clinical Guidance - Clinical Recommendations
Pharmacy Benefits Management Services
Menu
Clinical Guidance - Clinical Recommendations
- Alcohol Use Disorder Pharmacotherapy (Acamprosate, Naltrexone, Disulfiram) Recommendations for Use
- Alpha-blocker Combination in PTSD and BPH
- Alpha Blockers (Clinically Uroselective Alfuzosin Silodosin Tamsulosin) Clinical Recommendations
- Anesthesia (Topical) for Surfaces of the Nasopharynx, Oropharynx, Laryngotracheal Region and Airway, Guidance for Use
- Angiotensin II Receptor Antagonists, Clinical Recommendations
- Anticoagulation, Special Considerations for Women of Reproductive Age
- Antipsychotic Selection Algorithm Schizophrenia June 2012
- Beta-Adrenergic Blockers (Heart Failure), Clinical Recommendations
- Clopidogrel and Pharmacogenomic Testing
- Colchicine-Guidance for Use in the Management of Gout
- Combination Therapy in Tobacco Use Cessation, Recommendations
- Duloxetine for Chronic Pain Conditions, Recommendations for Use
- Dysphagia, Recommendations for Medication Assessment
- Gram-Positive Recs for Use Ceftaroline, daptomycin, linezolid, quin-dalf, tedizolid, telavancin, tigecycline (revised Mar 2015)
- Gram-Positive Recs for Use for Newer MRSA Agents (revised June 2015)
- Guidance for Disease Modifying Therapy Selection in Multiple Sclerosis
- Home Glucose Monitoring Test Strips, Dispensing Guidance
- Hydroxyethyl Starch (HES) Solutions in Critically Ill or Septic Patients-Clinical Recommendations
- Initial Management of Multiple Myeloma
- Insomnia Management Updates and Nonpharmacological VA Resources
- Interim Recommendations for Managing Dyslipidemia-Cardiovascular Risk in Veteran Patients
- Iron (Intravenous) in CKD, Clinical Recommendations
- Methadone, Dosing Recommendations
- Mineralocorticoid Receptor Antagonists (Eplerenone, Spironolactone) in Heart Failure, Recommendations for Use (Updated per 2013 ACCF/AHA Heart Failure Guideline)
- Naloxone HCL Rescue Kits Recommendations for Use
- Osteoporosis Algorithms Injectable Alternatives
- PDE5I BPH-LUTS Evidence & Penile Rehabilitation: Summary and Recommendations
- Pentoxifyline, Formulary Considerations
- Phosphate Binder (lanthanum, sevelamer, ferric citrate, sucroferric oxyhydroxide) Recommendations for Use
- Rifapentine, CDC Recommendations for INH-Rifapentine DOT Regimen for latent TB
- Simvastatin (Labeling Changes), Clinical Recommendations
- Simvastatin 80 mg Summary Guidance for Providers (December 2011)
- Simvastatin 80 mg-PBM-MAP-VPE Detailed Guidance-(December 2011)
- Sodium Phosphate Sodium Biphosphate Enema, Safety Considerations Rev Sep 2016
- Statin-fibrate safety report-Final
- Tranexamic Acid in TKA or THA
- Transgender Care, Cross-Sex Hormone Therapy (Feb 2012)
- Tyrosine Kinase Inhibitor (TKI) Flow Chart for the Treatment of CML
- Ulipristal acetate (ella) Recommendations for Use
- Vitamins to Reduce Risk of Progression in ARMD (AREDS2 Overview)
